Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache
NCT07714369Phase 2Not yet recruiting
- Sponsor
- UTHealth Houston
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of zavegepant in Cluster Headache (CH), sponsored by UTHealth Houston. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
zavegepant
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT07714369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07714369.